Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Cited by (1,003)

Items 601–700 of 1,003

1. LY303511 Enhances TRAIL Sensitivity of SHEP-1 Neuroblastoma Cells via Hydrogen Peroxide–Mediated Mitogen-Activated Protein Kinase Activation and Up-regulation of Death Receptors
   Kirthan Shenoy, Yongfei Wu, Shazib Pervaiz · 2009 · Cancer Research
2. Sensitization of TRAIL-Induced Cell Death by 20(S)-Ginsenoside Rg3 via CHOP-Mediated DR5 Upregulation in Human Hepatocellular Carcinoma Cells
   Ju‐Yeon Lee, Kyung Hee Jung, Michael J. Morgan, Yi-Rae Kang, Hee‐Seung Lee, Gi-Bang Koo, Soon‐Sun Hong, Sung Won Kwon, You Sun Kim · 2012 · Molecular Cancer Therapeutics
3. Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells
   Yumin Oh, Ogyi Park, Magdalena Swierczewska, James P. Hamilton, Jong Sung Park, Tae Hyung Kim, Sung‐Mook Lim, Hana Eom, Dong‐Gyu Jo, Choong‐Eun Lee et al. · 2015 · Hepatology
4. Life and death signaling pathways contributing to skin cancer.
   B. Nickoloff, Jian-Zhong Qin, V. Chaturvedi, P. Bacon, Jeffrey R. Panella, M. Denning · 2002 · Journal of Investigative Dermatology Symposium Proceedings
5. Hypoxia Inhibition of Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
   Sang‐Youel Park, Timothy R. Billiar, Dai‐Wu Seol · 2002 · Biochemical and Biophysical Research Communications
6. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D
   A Olsson, T Diaz, Miguel Aguilar‐Santelises, Anders Österborg, Fredrik Celsing, Mikael Jondal, LM Osorio · 2001 · Leukemia
7. Intra- and Interdimeric Caspase-8 Self-Cleavage Controls Strength and Timing of CD95-Induced Apoptosis
   Kallenberger, Stefan M., Beaudouin, Joël, Claus, Juliane, Fischer, Carmen, Sorger, Peter K., Legewie, Stefan, Eils, Roland · 2014 · Science Signaling
8. Emerging applications of bacteria as antitumor agents
   Vipin Chandra Kalia, Sanjay K. S. Patel, Byung‐Kwan Cho, Thomas Keith Wood, Jung-Kul Lee · 2021 · Seminars in Cancer Biology
9. Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL
   Norman Kock, Randa Kasmieh, Ralph Weissleder, Khalid Shah · 2007 · Neoplasia
10. Tumor necrosis factor family ligand–receptor binding
    Gongyi Zhang · 2004 · Current Opinion in Structural Biology
11. ROS and CHOP Are Critical for Dibenzylideneacetone to Sensitize Tumor Cells to TRAIL through Induction of Death Receptors and Downregulation of Cell Survival Proteins
    Sahdeo Prasad, Vivek Ramshankar Yadav, Jayaraj Ravindran, Bharat Bhushan Aggarwal · 2010 · Cancer Research · Retracted
12. Suramin inhibits death receptor–induced apoptosis in vitro and fulminant apoptotic liver damage in mice
    Sören T. Eichhorst, Andreas Krueger, Susanne Sebens Müerköster, Stefanie C. Fas, Alexander Golks, Uwe Gruetzner, Louise Schubert, Christine Opelz, M Bilzer, Alexander L. Gerbes et al. · 2004 · Nature Medicine
13. Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis
    Tomoyuki Kawakita, Katsuya Shiraki, Yutaka Yamanaka, Yumi Yamaguchi, Yukiko Saitou, Naoyuki Enokimura, Norihiko Yamamoto, Hiroshi Okano, Kazushi Sugimoto, Kazumoto Murata et al. · 2004 · Biochemical and Biophysical Research Communications
14. Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells
    Xiao Zhang, Xiang Zhang, Shijie Hu, Minhua Zheng, Jie Zhang, Jianhui Zhao, Xiaofang Zhang, Bo Yan, Lintao Jia, Jing Zhao et al. · 2017 · Nucleic Acids Research
15. Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates
    Santiago Grijalvo, Adele Alagia, Andreia F. Jorge, Ramón Eritja · 2018 · Genes
16. c-E10 Is a Caspase-recruiting Domain-containing Protein That Interacts with Components of Death Receptors Signaling Pathway and Activates Nuclear Factor-κB
    Antonio Costanzo, Chantal Guiet, Pasquale Vito · 1999 · Journal of Biological Chemistry
17. Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand and Chemotherapy Cooperate to Induce Apoptosis in Mesothelioma Cell Lines
    Weihong Liu, Ethan E. Bodle, Jessica Y. Chen, Mingxing Gao, GD Rosen, V. Courtney Broaddus · 2001 · American Journal of Respiratory Cell and Molecular Biology
18. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells
    C.-Y. Jin, Dong‐Oh Moon, J.-D. Lee, M.-S. Heo, Yung Hyun Choi, C.-M. Lee, Y.-M. Park, Gi‐Young Kim · 2006 · Carcinogenesis
19. Emerging roles of hypoxia‐inducible factors and reactive oxygen species in cancer and pluripotent stem cells
    Shigeo Saito, Ying‐Chu Lin, Ming‐Ho Tsai, Chang‐Shen Lin, Yoshinobu Murayama, Ryuji Sato, Kazunari K. Yokoyama · 2015 · The Kaohsiung Journal of Medical Sciences
20. Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature
    Jan Jacob Koornstra, Steven de Jong, Harry Hollema, Elisabeth G.E. de Vries, JAN H. KLEIBEUKER · 2002 · Critical Reviews in Oncology/Hematology
21. Improved Antitumor Activity and Tumor Targeting of NH2-Terminal–Specific PEGylated Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand
    Su Young Chae, Tae Hyung Kim, Kyeongsoon Park, Cheng‐Hao Jin, Sohee Son, Seulki Lee, Yu Seok Youn, Kwangmeyung Kim, Dong‐Gyu Jo, Ick Chan Kwon et al. · 2010 · Molecular Cancer Therapeutics
22. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells
    Susan K. H. Gillespie, Jodie M. Borrow, Xu Dong Zhang, Peter Hersey · 2006 · APOPTOSIS
23. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
    Ahmed M El-Zawahry, John C. McKillop, Christina Voelkel‐Johnson · 2005 · BMC Cancer
24. Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells
    Katharina Clodi, Doris Wimmer, Yang Li, Raymond G. Goodwin, Ulrich Jaeger, Georg Mann, H. Gadner, Anas Younes · 2000 · British Journal of Haematology
25. Interferon γ Enhances the Effectiveness of Tumor Necrosis Factor-Related Apoptosis–Inducing Ligand Receptor Agonists in a Xenograft Model of Ewing’s Sarcoma
    Melinda S. Merchant, Xuezhong Yang, Fraia Melchionda, María Elena Romero, Ruth Klein, Carol J. Thiele, Maria Tsokos, H U Kontny, Crystal Lee Mackall · 2004 · Cancer Research
26. Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways
    Marianne van Dijk, Anna McCormick, Tamas Sessler, Afshin Samali A, Éva Szegezdi · 2013 · Cell Death and Disease
27. TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
    Mark H. Tuthill, Antonella Montinaro, Julia Zinngrebe, Katharina Prieske, Peter Dráber, Silvia Prieske, Thomas E. Newsom-Davis, Silvia von Karstedt, Jonathan D. Graves, Henning Walczak · 2014 · Oncogene
28. Efficient TRAIL-R1/DR4-Mediated Apoptosis in Melanoma Cells by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
    Bahtier M. Kurbanov, Christoph C. Geilen, Lothar F. Fecker, Constantin E. Orfanos, Jürgen Eberle · 2005 · Journal of Investigative Dermatology
29. Activation of Wnt/β-Catenin Signaling Increases Apoptosis in Melanoma Cells Treated with Trail
    Zachary Franklin Zimmerman, Rima M. Kulikauskas, Karol Bomsztyk, Randall T. Moon, Andy J. Chien · 2013 · PLoS ONE
30. Caspase-8 cleaves its substrates from the plasma membrane upon CD95-induced apoptosis
    Joël Beaudouin, Clarissa Liesche, Sabine Aschenbrenner, Maximilian Hörner, Roland Eils · 2013 · Cell Death and Differentiation
31. Tumor-Infiltrating CD4+ T Lymphocytes Express APO2 Ligand (APO2L)/TRAIL upon Specific Stimulation with Autologous Lung Carcinoma Cells: Role of IFN-α on APO2L/TRAIL Expression and -Mediated Cytotoxicity
    Guillaume Dorothée, Isabelle Vergnon, Jeanne Menez, Hamid Echchakir, Dominique H Grunenwald, Marek Z. Kubin, Salem Chouaı̈b, Fathia Mami‐Chouaib · 2002 · The Journal of Immunology
32. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil
    Y Mizutani, H Nakanishi, O Yoshida, Masakazu Fukushima, Benjamin Bonavida, T Miki · 2002 · European Journal of Cancer
33. Modeling Dynamics of Cell-to-Cell Variability in TRAIL-Induced Apoptosis Explains Fractional Killing and Predicts Reversible Resistance
    François Bertaux, Szymon Stoma, Dirk Drasdo, Grégory Batt · 2014 · PLoS Computational Biology
34. Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL
    Vitaliy O. Kaminskyy, Olga V. Surova, Alena Hyršlová Vaculová, Boris Zhivotovsky · 2011 · Carcinogenesis
35. TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling
    Abderrahmane Guerrache, Olivier Micheau · 2024 · Cells
36. Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders
    Anas Younes, Bharat B Aggarwal · 2003 · Cancer
37. TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT
    Najoua Lalaoui, Aymeric Morlé, Delphine Mérino, Guillaume Jacquemin, Elisabetta Iessi, Alexandre Morizot, Sarah Shirley, Bruno Robert, Éric Solary, Carmen Garrido et al. · 2011 · PLoS ONE
38. The C-terminal Tails of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Fas Receptors Have Opposing Functions in Fas-associated Death Domain (FADD) Recruitment and Can Regulate Agonist-specific Mechanisms of Receptor Activation
    Lance R. Thomas, Ronald L. Johnson, John C. Reed, Andrew M. Thorburn · 2004 · Journal of Biological Chemistry
39. Intranasal delivery of stem cells as therapy for central nervous system disease
    Yànhuá Lǐ, Ling Feng, Guang‐Xian Zhang, Cun‐Gen Ma · 2015 · Experimental and Molecular Pathology
40. Inducible Hsp70 in the Regulation of Cancer Cell Survival: Analysis of Chaperone Induction, Expression and Activity
    Elisa Zorzi, Paolo Bonvini · 2011 · Cancers
41. An IL-2-Dependent Switch Between CD95 Signaling Pathways Sensitizes Primary Human T Cells Toward CD95-Mediated Activation-Induced Cell Death
    Ingo Schmitz, Andreas Krueger, Sven Baumann, Henning Schulze‐Bergkamen, Peter H. Krammer, Sabine Kirchhoff · 2003 · The Journal of Immunology
42. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-κB activity
    Christian Wuchter, Daniel Krappmann, Zhen Cai, Velia Ruppert, Claus Scheidereit, Bernd Dörken, W-D Ludwig, Leonid Karawajew · 2001 · Leukemia
43. Ruthenium Polypyridyl Complex Inhibits Growth and Metastasis of Breast Cancer Cells by Suppressing FAK signaling with Enhancement of TRAIL-induced Apoptosis
    Wenqiang Cao, Wenjie Zheng, Tianfeng Chen · 2015 · Scientific Reports
44. Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins
    B Schneider, Sabine Münkel, Anja Krippner‐Heidenreich, Ingo Grunwald, Winfried S. Wels, Harald Wajant, Klaus Pfizenmaier, Jeannette Gerspach · 2010 · Cell Death and Disease
45. Exploring death receptor pathways as selective targets in cancer therapy
    Maria Russo, Annalisa Mupo, Carmela Spagnuolo, Gian Luigi Russo · 2010 · Biochemical Pharmacology
46. Tissue decellularization by activation of programmed cell death
    Paul Emile Bourgine, Benjamin E. Pippenger, Atanas Todorov, L. Tchang, Iván Martín · 2013 · Biomaterials
47. Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective
    Marcel Verheij, Conchita Vens, Baukelien van Triest · 2010 · Drug Resistance Updates
48. Aspirin Sensitizes Cancer Cells to TRAIL–Induced Apoptosis by Reducing Survivin Levels
    Meiling Lü, Anne M. Strohecker, Feng Chen, Toni Kwan, Joshua D. Bosman, V. Craig Jordan, Vincent L. Cryns · 2008 · Clinical Cancer Research
49. Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL
    Jinrong Cheng, Bonnie Lee Hylander, Maria R. Baer, Xing Chen, Elizabeth A. Repasky · 2006 · Molecular Cancer Therapeutics
50. TRAIL-death receptor endocytosis and apoptosis are selectively regulated by dynamin-1 activation
    Carlos R. Reis, Ping‐Hung Chen, Nawal Bendris, Sandra L. Schmid · 2017 · Proceedings of the National Academy of Sciences
51. Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin
    Kerstin Schultze, Barbara C. Böck, Anika Eckert, Lena Oevermann, Dirk Ramacher, Otmar Dieter Wiestler, Wilfried Roth · 2006 · APOPTOSIS
52. Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
    Margherita Iaboni, Valentina M. Russo, Raffaela Fontanella, Giuseppina Roscigno, Danilo Fiore, Elvira Donnarumma, Carla Lucia Esposito, Cristina Quintavalle, Paloma H. Giangrande, Vittorio de Franciscis et al. · 2016 · Molecular Therapy — Nucleic Acids
53. CASC2/miR-24/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8/caspase-3
    Xiaoxin Jin, Lifeng Cai, Changfa Wang, Xiaofeng Deng, Shengen Yi, Zhao Lei, Qiangsheng Xiao, Hongbo Xu, Hongwu Luo, Jichun Sun · 2018 · Cell Death and Disease
54. Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy
    Olivia Adaly Diaz Arguello, Hidde J. Haisma · 2021 · Cancers
55. The ‘kiss of death’ by dendritic cells to cancer cells
    C W Chan, Franck Housseau · 2007 · Cell Death and Differentiation
56. PI‐3K/Akt and NF‐κB/IκBα pathways are activated in Jurkat T cells in response to TRAIL treatment
    Giorgio Zauli, Silvia Sancilio, Amelia Cataldi, Nadia Sabatini, Domenico Bosco, Roberta Di Pietro · 2004 · Journal of Cellular Physiology
57. Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature
    Lin Cao, Pan Du, Shu-Han Jiang, Guang‐Hui Jin, Qi-Lai Huang, Zi‐Chun Hua · 2008 · Molecular Cancer Therapeutics
58. PRMT5, a Novel TRAIL Receptor-Binding Protein, Inhibits TRAIL-Induced Apoptosis via Nuclear Factor-κB Activation
    Hiroshi Tanaka, Yutaka Hoshikawa, Tomoko Oh‐hara, Sumie Koike, Mikihiko Naito, Tetsuo Noda, Hiroyuki Arai, Takashi Tsuruo, Naoya Fujita · 2009 · Molecular Cancer Research
59. Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles
    Shashank Tummala, M. N. Satish Kumar, Sai Kiran S. S. Pindiprolu · 2016 · Drug Delivery
60. TRAIL Triggers Apoptosis in Human Malignant Glioma Cells Through Extrinsic and Intrinsic Pathways
    Jin Hyang Song, Doyoun K. Song, Beata Pyrzyńska, Kenneth C. Petruk, Erwin G. Van Meir, Chunhai Hao · 2003 · Brain Pathology
61. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor
    Shohei Koyama, Naoto Koike, Shinya Adachi · 2002 · Journal of Cancer Research and Clinical Oncology
62. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas
    Sung‐Hoon Kim, Junghee Kang, Jingbo Qiao, Robert P. Thomas, Bernard Mark Evers, Dai H. Chung · 2004 · Journal of Pediatric Surgery
63. Partial Contribution of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)/TRAIL Receptor Pathway to Antitumor Effects of Interferon-α/5-Fluorouracil against Hepatocellular Carcinoma
    Tameyoshi Yamamoto, Hiroaki Nagano, Masato Sakon, Hisashi Wada, Hidetoshi Eguchi, Motoi Kondo, Bazarragchaa Damdinsuren, Hideo Ôta, Masato Nakamura, Hiroshi Wada et al. · 2004 · Clinical Cancer Research
64. TRAIL/Apo-2 Ligand Induces Primary Plasma Cell Apoptosis
    Josie Ursini‐Siegel, Wenli Zhang, Anne Altmeyer, Eunice N. Hatada, Richard K G Do, Hideo Yagita∥, Selina Chen‐Kiang · 2002 · The Journal of Immunology
65. TRAILblazing Strategies for Cancer Treatment
    Anna-Laura Kretz, Anna Trauzold, Andreas Hillenbrand, Uwe Knippschild, Doris Henne‐Bruns, Silvia von Karstedt, Johannes Lemke · 2019 · Cancers
66. Apoptosis and Pathogenesis of Melanoma and Nonmelanoma Skin Cancer
    Peter Erb, Jingmin Ji, Erwin Kump, Ainhoa Mielgo, Marion Wernli · 2009 · Advances in experimental medicine and biology
67. IFN‐γ enhances TRAIL‐induced apoptosis through IRF‐1
    Sang‐Youel Park, Jae‐Won Seol, Youjin Lee, Jong‐Hoo Cho, Hyung‐Sub Kang, In‐Shik Kim, Soo‐Hyun Park, Tae‐Hyoung Kim, John Hosei Yim, Moonil Kim et al. · 2004 · European Journal of Biochemistry
68. Apoptosis and cancer: When BAX is TRAILing away
    Wilfried Roth, John C. Reed · 2002 · Nature Medicine
69. Translation Inhibitors Sensitize Prostate Cancer Cells to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) by Activating c-Jun N-terminal Kinase
    Nand Kishore Sah, Anupama Munshi, John F. Kurland, Timothy J. McDonnell, Bing Su, Raymond E. Meyn · 2003 · Journal of Biological Chemistry
70. TISSUE DISTRIBUTION, STABILITY, AND PHARMACOKINETICS OF APO2 LIGAND/TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND IN HUMAN COLON CARCINOMA COLO205 TUMOR-BEARING NUDE MICE
    Hong Xiang, Cindy B. Nguyen, Sean K. Kelley, Noel O. Dybdal, Enrique Escandón · 2004 · Drug Metabolism and Disposition
71. Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy
    Stelios Bouralexis, David M. Findlay, Gerald J. Atkins, Agatha Labrinidis, Shelley J. Hay, Andreas Evdokiou · 2003 · British Journal of Cancer
72. Evidence that the human death receptor 4 is regulated by activator protein 1
    Baoxiang Guan, Ping Yue, Reuben Lotan, Shi‐Yong Sun · 2002 · Oncogene
73. Prognostic Significance of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand and Its Receptors in Adjuvantly Treated Stage III Colon Cancer Patients
    Caroline M. M. van Geelen, Jantine L. Westra, Elisabeth G.E. de Vries, Wytske Boersma‐van Ek, Nynke Zwart, Harry Hollema, H. Marike Boezen, Nanno H. Mulder, John Th. M. Plukker, Steven de Jong et al. · 2006 · Journal of Clinical Oncology
74. Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide–Akt–FLIP pathway
    Seon Young Nam, Andrew A. Amoscato, Yong Jun Lee · 2002 · Oncogene
75. Potential of gene therapy for brain tumors
    P. Y.P. Lam · 2001 · Human Molecular Genetics
76. TRAIL-based gene delivery and therapeutic strategies
    Huihai Zhong, Huiyuan Wang, Jian Li, Yongzhuo Huang · 2019 · Acta Pharmacologica Sinica
77. Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics
    Yu Chen, Xiaoqing Liu, Yanxia Guo, Jianchuan Wang, Dingxiao Zhang, Mei Jun Yang, Junfeng Shi, Wenzhi Tan, Jin Hai Zheng · 2021 · Acta Biomaterialia
78. Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression
    Marc Bleumink, Rebecca Köhler, Marco Giaisi, Peter Proksch, Peter H. Krammer, M Li-Weber · 2010 · Cell Death and Differentiation
79. Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy
    Zhengqiang Yuan, Krishna Kalyan Kolluri, Elizabeth K. Sage, Kate H.C. Gowers, Sam M. Janes · 2015 · Cytotherapy
80. Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles
    Jaehong Kim, Ji‐Hyun Yeom, Jeong‐Jae Ko, Min Su Han, Kangseok Lee, Soon-Young Na, Jeehyeon Bae · 2011 · Journal of Biotechnology
81. Salmonella and cancer: from pathogens to therapeutics.
    Paulina Chorobik, Dominik Czaplicki, Karolina Ossysek, Joanna Bereta · 2013 · Acta Biochimica Polonica
82. Apoptosis pathways as promising targets for skin cancer therapy
    Jürgen Eberle, Lothar F. Fecker, Tobias Forschner, Claas Ulrich, Joachim Röwert‐Huber, Eggert Stockfleth · 2007 · British Journal of Dermatology
83. Strains, Mechanism, and Perspective:Salmonella-Based Cancer Therapy
    Chengzhi Wang, Robert A. Kazmierczak, A. Eisenstark · 2016 · International Journal of Microbiology
84. Apoptosis in liver disease
    Marcus Schuchmann, Peter R. Galle · 2001 · European Journal of Gastroenterology & Hepatology
85. Targeting TRAIL Agonistic Receptors for Cancer Therapy
    Carmelo Carlo‐Stella, Cristiana Lavazza, Alberta Locatelli, Lucia Viganò, Alessandro M. Gianni, Luca Gianni · 2007 · Clinical Cancer Research
86. Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells
    Yong Jun Lee, Kun H Lee, Hyeong-Reh Choi Kim, John Milburn Jessup, Dai‐Wu Seol, Tae‐Hyoung Kim, Timothy R. Billiar, Young K Song · 2001 · Oncogene
87. Regulation of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Thyroid Carcinoma Cells
    Vassiliki Poulaki, Constantine S. Mitsiades, Vassiliki Kotoula, Sophia Tseleni-Balafouta, Avi Ashkenazi, Demetrios A. Koutras, Nicholas Mitsiades · 2002 · American Journal Of Pathology
88. CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells
    Alicia Algeciras-Schimnich, Stacey R. Vlahakis, Angelina Villası́s-Keever, Timothy S. Gomez, Carrie J. Holtz Heppelmann, Germán Bou, Carlos V. Payá · 2002 · AIDS
89. The short splice form of Casper/c‐FLIP is a major cellular inhibitor of TRAIL‐induced apoptosis
    Lianghua Bin, Xiaoyan Li, Liang‐Guo Xu, Hong‐Bing Shu · 2001 · FEBS Letters
90. Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor α-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)–induced Apoptosis of Bcr-Abl–positive Human Acute Leukemia Cells
    Ramadevi Nimmanapalli, Mercedes Porosnicu, Diep N. Nguyen, Elizabeth Worthington, Erica O’Bryan, Charles L. Perkins, Kapil N. Bhalla · 2019 · Clinical Cancer Research
91. TRAIL death receptors and cancer therapeutics
    Yue Huang, M. Saeed Sheikh · 2006 · Toxicology and Applied Pharmacology
92. Conatumumab (AMG 655) coated nanoparticles for targeted pro-apoptotic drug delivery
    François Fay, Kirsty M. McLaughlin, Donna M. Small, Dean Anthony Fennell, Patrick G. Johnston, Daniel B. Longley, Christopher J. Scott · 2011 · Biomaterials
93. Apigenin Sensitizes Prostate Cancer Cells to Apo2L/TRAIL by Targeting Adenine Nucleotide Translocase-2
    Masakatsu Oishi, Yosuke Iizumi, Tomoyuki Taniguchi, Wakana Goi, Tsuneharu Miki, Toshiyuki Sakai · 2013 · PLoS ONE
94. Antitumor Activity and Prolonged Expression from a TRAIL-Expressing Adenoviral Vector
    Jeongwu Lee, Monika Hampl, Paul S. Albert, Howard Alan Fine · 2002 · Neoplasia
95. Cancer: Novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway
    Erika Cretney, Kazuyoshi Takeda, Mark John Smyth · 2006 · The International Journal of Biochemistry & Cell Biology
96. Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis
    Ja-Young Kim, Yun‐Hee Kim, Inik Chang, Sunshin Kim, Youngmi Kim Pak, Byung‐Ha Oh, Hideo Yagita∥, Yong‐Keun Jung, Young J. Oh, Myung‐Shik Lee · 2002 · Oncogene
97. Adenovirus E1A Oncogene Expression in Tumor Cells Enhances Killing by TNF-Related Apoptosis-Inducing Ligand (TRAIL)
    John M. Routes, Sharon Ryan, Amanda Clase, Tanya A. Miura, Alicia Kuhl, Terry A. Potter, James L. Cook · 2000 · The Journal of Immunology
98. The Antitumor Effect of Gene-Engineered Exosomes in the Treatment of Brain Metastasis of Breast Cancer
    Minchen Liu, Yulan Hu, Guiqian Chen · 2020 · Frontiers in Oncology
99. Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage
    Camille Ternet, Christina Kiel · 2021 · Cell Communication and Signaling
100. Modulation of the CD95-Induced Apoptosis: The Role of CD95 N-Glycosylation
     Olga Shatnyeva, Andriy V. Kubarenko, Claudia E.M. Weber, Alexander Pappa, Reinhard Schwartz‐Albiez, Alexander N.R. Weber, Peter H. Krammer, Inna N. Lavrik · 2011 · PLoS ONE